

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.10217209 |
| 2 | negative regulation of macroautophagy (GO:0016242) | 6.07330760 |
| 3 | auditory receptor cell stereocilium organization (GO:0060088) | 5.53715867 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 5.48947427 |
| 5 | post-embryonic morphogenesis (GO:0009886) | 4.97242163 |
| 6 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.83922724 |
| 7 | vocalization behavior (GO:0071625) | 4.79470275 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.72793245 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.67561580 |
| 10 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.36790719 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.27065856 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.21474654 |
| 13 | energy homeostasis (GO:0097009) | 4.20929290 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.16452923 |
| 15 | cellular anion homeostasis (GO:0030002) | 4.15595059 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.14109344 |
| 17 | positive regulation of neurological system process (GO:0031646) | 4.12094726 |
| 18 | positive regulation of neurotransmitter transport (GO:0051590) | 4.03661427 |
| 19 | synaptic vesicle maturation (GO:0016188) | 4.02251693 |
| 20 | presynaptic membrane assembly (GO:0097105) | 3.84601885 |
| 21 | negative regulation of meiosis (GO:0045835) | 3.84418633 |
| 22 | presynaptic membrane organization (GO:0097090) | 3.84387910 |
| 23 | inner ear receptor stereocilium organization (GO:0060122) | 3.76661005 |
| 24 | sulfate transmembrane transport (GO:1902358) | 3.75606892 |
| 25 | neuron remodeling (GO:0016322) | 3.74785504 |
| 26 | neurotransmitter transport (GO:0006836) | 3.74658863 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.71984160 |
| 28 | insulin secretion (GO:0030073) | 3.68463684 |
| 29 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.65079210 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 3.58173274 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 3.57153052 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 3.56611285 |
| 33 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.54702439 |
| 34 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.54334268 |
| 35 | lateral ventricle development (GO:0021670) | 3.49531495 |
| 36 | regulation of neurotransmitter levels (GO:0001505) | 3.45126663 |
| 37 | proline transport (GO:0015824) | 3.41853947 |
| 38 | trivalent inorganic anion homeostasis (GO:0072506) | 3.41068623 |
| 39 | phosphate ion homeostasis (GO:0055062) | 3.41068623 |
| 40 | regulation of vesicle fusion (GO:0031338) | 3.38924896 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.36503917 |
| 42 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.33286871 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.32625145 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.28275628 |
| 45 | axonal fasciculation (GO:0007413) | 3.28135543 |
| 46 | chemosensory behavior (GO:0007635) | 3.28081025 |
| 47 | serotonin metabolic process (GO:0042428) | 3.27782222 |
| 48 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.27551953 |
| 49 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.25909647 |
| 50 | glycine transport (GO:0015816) | 3.24848335 |
| 51 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.19838927 |
| 52 | postsynaptic membrane organization (GO:0001941) | 3.19563933 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 3.18688431 |
| 54 | bicarbonate transport (GO:0015701) | 3.16500418 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.14686341 |
| 56 | startle response (GO:0001964) | 3.12743147 |
| 57 | auditory behavior (GO:0031223) | 3.10256143 |
| 58 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.09520913 |
| 59 | long term synaptic depression (GO:0060292) | 3.07679627 |
| 60 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.02985229 |
| 61 | signal release (GO:0023061) | 3.02965390 |
| 62 | dendritic spine morphogenesis (GO:0060997) | 3.02839365 |
| 63 | dendritic spine organization (GO:0097061) | 3.02587146 |
| 64 | sulfate transport (GO:0008272) | 3.01288352 |
| 65 | primary amino compound metabolic process (GO:1901160) | 3.00191456 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.00108636 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.00101826 |
| 68 | neuronal ion channel clustering (GO:0045161) | 2.97959575 |
| 69 | inositol metabolic process (GO:0006020) | 2.97804167 |
| 70 | positive regulation of dendritic spine development (GO:0060999) | 2.97577544 |
| 71 | detection of calcium ion (GO:0005513) | 2.95416036 |
| 72 | regulation of synapse maturation (GO:0090128) | 2.95294364 |
| 73 | neuron recognition (GO:0008038) | 2.94844343 |
| 74 | neuromuscular synaptic transmission (GO:0007274) | 2.94681446 |
| 75 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.94247550 |
| 76 | negative regulation of response to nutrient levels (GO:0032108) | 2.94247550 |
| 77 | synaptic vesicle exocytosis (GO:0016079) | 2.94021919 |
| 78 | potassium ion homeostasis (GO:0055075) | 2.93996225 |
| 79 | regulation of dendritic spine development (GO:0060998) | 2.93574538 |
| 80 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93422443 |
| 81 | glutamate secretion (GO:0014047) | 2.93147262 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 2.92026027 |
| 83 | neuron-neuron synaptic transmission (GO:0007270) | 2.90386113 |
| 84 | positive regulation of vascular permeability (GO:0043117) | 2.89455921 |
| 85 | exploration behavior (GO:0035640) | 2.88585659 |
| 86 | transmission of nerve impulse (GO:0019226) | 2.88501443 |
| 87 | righting reflex (GO:0060013) | 2.88488962 |
| 88 | exogenous drug catabolic process (GO:0042738) | 2.88301663 |
| 89 | calcium ion-dependent exocytosis (GO:0017156) | 2.88210288 |
| 90 | glycoside metabolic process (GO:0016137) | 2.87774169 |
| 91 | response to dietary excess (GO:0002021) | 2.87275105 |
| 92 | prostate gland growth (GO:0060736) | 2.86949209 |
| 93 | synaptic transmission (GO:0007268) | 2.85492335 |
| 94 | glycerophospholipid catabolic process (GO:0046475) | 2.85075581 |
| 95 | protein localization to synapse (GO:0035418) | 2.84942069 |
| 96 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.84726729 |
| 97 | regulation of neurotransmitter secretion (GO:0046928) | 2.84200085 |
| 98 | negative regulation of dendrite development (GO:2000171) | 2.83609395 |
| 99 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.82077025 |
| 100 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.81733842 |
| 101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81569162 |
| 102 | innervation (GO:0060384) | 2.81388545 |
| 103 | vesicle transport along microtubule (GO:0047496) | 2.81037999 |
| 104 | membrane depolarization (GO:0051899) | 2.80585707 |
| 105 | inositol phosphate catabolic process (GO:0071545) | 2.80552764 |
| 106 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.78658399 |
| 107 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.77365646 |
| 108 | neuron cell-cell adhesion (GO:0007158) | 2.77189959 |
| 109 | peptidyl-lysine dimethylation (GO:0018027) | 2.76603747 |
| 110 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.76579481 |
| 111 | glycosphingolipid biosynthetic process (GO:0006688) | 2.76059914 |
| 112 | response to pheromone (GO:0019236) | 2.75777685 |
| 113 | cerebellar granule cell differentiation (GO:0021707) | 2.75158763 |
| 114 | neurotransmitter secretion (GO:0007269) | 2.74878251 |
| 115 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.73488602 |
| 116 | pigment granule transport (GO:0051904) | 2.73287140 |
| 117 | catecholamine transport (GO:0051937) | 2.73087072 |
| 118 | pigment granule localization (GO:0051875) | 2.72933934 |
| 119 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72270267 |
| 120 | detection of biotic stimulus (GO:0009595) | 2.72159859 |
| 121 | regulation of neurotransmitter transport (GO:0051588) | 2.70559368 |
| 122 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.69124053 |
| 123 | brain morphogenesis (GO:0048854) | 2.68636563 |
| 124 | regulation of postsynaptic membrane potential (GO:0060078) | 2.67615104 |
| 125 | potassium ion transmembrane transport (GO:0071805) | 2.67293896 |
| 126 | cellular potassium ion transport (GO:0071804) | 2.67293896 |
| 127 | establishment of pigment granule localization (GO:0051905) | 2.67131958 |
| 128 | long-term synaptic potentiation (GO:0060291) | 2.66752611 |
| 129 | prepulse inhibition (GO:0060134) | 2.66274068 |
| 130 | synapse assembly (GO:0007416) | 2.66072676 |
| 131 | regulation of exocytosis (GO:0017157) | 2.66009566 |
| 132 | potassium ion import (GO:0010107) | 2.66004413 |
| 133 | intraspecies interaction between organisms (GO:0051703) | 2.64653591 |
| 134 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.64040355 |
| 135 | negative regulation of meiotic cell cycle (GO:0051447) | 2.57921842 |
| 136 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.57542276 |
| 137 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.57041315 |
| 138 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.56583358 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55288812 |
| 140 | drinking behavior (GO:0042756) | 2.55275096 |
| 141 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.52329975 |
| 142 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.51852619 |
| 143 | membrane hyperpolarization (GO:0060081) | 2.51209636 |
| 144 | neuronal action potential propagation (GO:0019227) | 2.48437120 |
| 145 | membrane depolarization during action potential (GO:0086010) | 2.48287113 |
| 146 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.48183350 |
| 147 | negative regulation of neurotransmitter transport (GO:0051589) | 2.47772613 |
| 148 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.46253892 |
| 149 | opioid receptor signaling pathway (GO:0038003) | 2.45236261 |
| 150 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.45064237 |
| 151 | regulation of synaptic plasticity (GO:0048167) | 2.43678223 |
| 152 | synaptic vesicle endocytosis (GO:0048488) | 2.41765750 |
| 153 | daunorubicin metabolic process (GO:0044597) | 15.9764155 |
| 154 | polyketide metabolic process (GO:0030638) | 15.9764155 |
| 155 | doxorubicin metabolic process (GO:0044598) | 15.9764155 |
| 156 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.3970000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.19860015 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66941066 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.11178928 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98456137 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87489613 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82071424 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74520922 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74520922 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.58204702 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58047819 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56163304 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.55579797 |
| 13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.45344694 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44167266 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37063446 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31130112 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29061820 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24393252 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23968513 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.22775371 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21693249 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12214468 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02442857 |
| 24 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73910590 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70362600 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63882072 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61572491 |
| 28 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58542965 |
| 29 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57425647 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54572978 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54272844 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53500931 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50127103 |
| 34 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49249597 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48918793 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47979415 |
| 37 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46689202 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45608247 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42677094 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42656948 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41216889 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.37697744 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37561753 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36473705 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34110522 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33737057 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33069882 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32587059 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29701681 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24169215 |
| 51 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.23480219 |
| 52 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22387651 |
| 53 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21219774 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.20984452 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.20930683 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20071216 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17793211 |
| 58 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17780112 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16638448 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16142444 |
| 61 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15741551 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15583341 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15495826 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14962960 |
| 65 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14190423 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13740523 |
| 67 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11096593 |
| 68 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10354363 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10177045 |
| 70 | AR_19668381_ChIP-Seq_PC3_Human | 1.09843160 |
| 71 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09267658 |
| 72 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09050835 |
| 73 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09023557 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07371670 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06793905 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06621204 |
| 77 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06111723 |
| 78 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05975329 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05933170 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05395371 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05138422 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05053089 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04687658 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04251181 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03807757 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03476504 |
| 87 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02206600 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02047244 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01575260 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01068281 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00260864 |
| 92 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99361005 |
| 93 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99078147 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98933091 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97715559 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97098339 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96165544 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96165544 |
| 99 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94804339 |
| 100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94759543 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94444995 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93953531 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93811645 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93252980 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93252980 |
| 106 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93182857 |
| 107 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93019472 |
| 108 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90955854 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90908035 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90080997 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89943257 |
| 112 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89767703 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89701785 |
| 114 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.89458665 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88901973 |
| 116 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88779066 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87232252 |
| 118 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86979659 |
| 119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86974390 |
| 120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86847523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005377_hearing/vestibular/ear_phenot | 4.96805362 |
| 2 | MP0003878_abnormal_ear_physiology | 4.96805362 |
| 3 | MP0008004_abnormal_stomach_pH | 4.61659766 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 4.55161908 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.78723647 |
| 6 | MP0003879_abnormal_hair_cell | 3.72467753 |
| 7 | MP0003880_abnormal_central_pattern | 3.41687344 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.22531765 |
| 9 | MP0000678_abnormal_parathyroid_gland | 3.16199882 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.81923625 |
| 11 | MP0001486_abnormal_startle_reflex | 2.53428338 |
| 12 | MP0009745_abnormal_behavioral_response | 2.46361227 |
| 13 | MP0001485_abnormal_pinna_reflex | 2.33175699 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.30805614 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.25093323 |
| 16 | MP0009046_muscle_twitch | 2.23392438 |
| 17 | MP0004270_analgesia | 2.23239945 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.22457980 |
| 19 | MP0002064_seizures | 2.17279936 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.10625847 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.10424306 |
| 22 | MP0002272_abnormal_nervous_system | 2.07930337 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.07807164 |
| 24 | MP0004742_abnormal_vestibular_system | 2.06851141 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.98788338 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.98442865 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.96899639 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.91824625 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.82786647 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.82760525 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.81177020 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.80523990 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.80381810 |
| 34 | MP0004858_abnormal_nervous_system | 1.79551434 |
| 35 | MP0003123_paternal_imprinting | 1.70823067 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.66846186 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.65050121 |
| 38 | MP0002184_abnormal_innervation | 1.62452221 |
| 39 | MP0001905_abnormal_dopamine_level | 1.59618243 |
| 40 | MP0002822_catalepsy | 1.59097581 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.58504997 |
| 42 | MP0004924_abnormal_behavior | 1.58504997 |
| 43 | MP0009697_abnormal_copulation | 1.58131058 |
| 44 | MP0001970_abnormal_pain_threshold | 1.48616015 |
| 45 | MP0004043_abnormal_pH_regulation | 1.47851887 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.44887868 |
| 47 | MP0002736_abnormal_nociception_after | 1.41538124 |
| 48 | MP0003121_genomic_imprinting | 1.40309758 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.37603378 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.33579935 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.29002861 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.25463745 |
| 53 | MP0001664_abnormal_digestion | 1.24336206 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.22552398 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.22285967 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.17694139 |
| 57 | MP0002693_abnormal_pancreas_physiology | 1.15529090 |
| 58 | MP0003646_muscle_fatigue | 1.13406290 |
| 59 | MP0003045_fibrosis | 1.12011784 |
| 60 | MP0003283_abnormal_digestive_organ | 1.09500752 |
| 61 | MP0004885_abnormal_endolymph | 1.08711699 |
| 62 | MP0003195_calcinosis | 1.08037120 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.06167229 |
| 64 | MP0001529_abnormal_vocalization | 1.05657162 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.05229927 |
| 66 | MP0003329_amyloid_beta_deposits | 1.03410712 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.01555201 |
| 68 | MP0000955_abnormal_spinal_cord | 1.00963256 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 0.96033709 |
| 70 | MP0000778_abnormal_nervous_system | 0.93489068 |
| 71 | MP0001963_abnormal_hearing_physiology | 0.93434751 |
| 72 | MP0008874_decreased_physiological_sensi | 0.93343536 |
| 73 | MP0003941_abnormal_skin_development | 0.90377776 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.89672362 |
| 75 | MP0004085_abnormal_heartbeat | 0.88150536 |
| 76 | MP0008872_abnormal_physiological_respon | 0.88059035 |
| 77 | MP0008569_lethality_at_weaning | 0.87550516 |
| 78 | MP0003633_abnormal_nervous_system | 0.86516800 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.86241657 |
| 80 | MP0003868_abnormal_feces_composition | 0.86159157 |
| 81 | MP0005253_abnormal_eye_physiology | 0.83907297 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.83856380 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.83232725 |
| 84 | MP0002882_abnormal_neuron_morphology | 0.81223142 |
| 85 | MP0003690_abnormal_glial_cell | 0.80433772 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.80275728 |
| 87 | MP0001984_abnormal_olfaction | 0.80214548 |
| 88 | MP0002928_abnormal_bile_duct | 0.79679059 |
| 89 | MP0001944_abnormal_pancreas_morphology | 0.79277287 |
| 90 | MP0000566_synostosis | 0.79178595 |
| 91 | MP0004147_increased_porphyrin_level | 0.77130585 |
| 92 | MP0005448_abnormal_energy_balance | 0.74828255 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.73806610 |
| 94 | MP0004133_heterotaxia | 0.73636309 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.73621401 |
| 96 | MP0001756_abnormal_urination | 0.73522750 |
| 97 | MP0005310_abnormal_salivary_gland | 0.71522374 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.70903697 |
| 99 | MP0003122_maternal_imprinting | 0.69758913 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.68778468 |
| 101 | MP0000639_abnormal_adrenal_gland | 0.68629256 |
| 102 | MP0003787_abnormal_imprinting | 0.68235059 |
| 103 | MP0003075_altered_response_to | 0.66326561 |
| 104 | MP0000920_abnormal_myelination | 0.66124508 |
| 105 | MP0003632_abnormal_nervous_system | 0.66100596 |
| 106 | MP0002229_neurodegeneration | 0.66019907 |
| 107 | MP0002163_abnormal_gland_morphology | 0.66017322 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.65293686 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.65002468 |
| 110 | MP0003634_abnormal_glial_cell | 0.63944623 |
| 111 | MP0002090_abnormal_vision | 0.62749177 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.62629197 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.62561078 |
| 114 | MP0001177_atelectasis | 0.61327264 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.61195821 |
| 116 | MP0005171_absent_coat_pigmentation | 0.59876973 |
| 117 | MP0003631_nervous_system_phenotype | 0.58969471 |
| 118 | MP0002938_white_spotting | 0.58832601 |
| 119 | MP0005187_abnormal_penis_morphology | 0.58681078 |
| 120 | MP0000026_abnormal_inner_ear | 0.57624239 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.56564346 |
| 122 | MP0005535_abnormal_body_temperature | 0.56480540 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.56175056 |
| 124 | MP0001188_hyperpigmentation | 0.55728392 |
| 125 | MP0004142_abnormal_muscle_tone | 0.54875224 |
| 126 | MP0003953_abnormal_hormone_level | 0.53896470 |
| 127 | MP0002152_abnormal_brain_morphology | 0.53854935 |
| 128 | MP0004233_abnormal_muscle_weight | 0.53735003 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.49428923 |
| 130 | MP0004510_myositis | 0.49207189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Unilateral renal agenesis (HP:0000122) | 8.72759169 |
| 2 | Parakeratosis (HP:0001036) | 8.51954781 |
| 3 | Alopecia of scalp (HP:0002293) | 7.20417571 |
| 4 | Abnormality of dental color (HP:0011073) | 6.54067585 |
| 5 | Follicular hyperkeratosis (HP:0007502) | 6.48734475 |
| 6 | Bilateral sensorineural hearing impairment (HP:0008619) | 6.33497072 |
| 7 | Absent eyebrow (HP:0002223) | 6.22248688 |
| 8 | Absent eyelashes (HP:0000561) | 5.71901808 |
| 9 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.46983997 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 5.46983997 |
| 11 | Hyperphosphatemia (HP:0002905) | 5.10625183 |
| 12 | Focal motor seizures (HP:0011153) | 4.86028839 |
| 13 | Recurrent corneal erosions (HP:0000495) | 4.74021682 |
| 14 | Cheilitis (HP:0100825) | 4.42493399 |
| 15 | Chronic otitis media (HP:0000389) | 4.21683216 |
| 16 | Limb dystonia (HP:0002451) | 4.19933266 |
| 17 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.17779805 |
| 18 | Tetany (HP:0001281) | 3.78935667 |
| 19 | Abolished electroretinogram (ERG) (HP:0000550) | 3.78659947 |
| 20 | Myokymia (HP:0002411) | 3.69680066 |
| 21 | Abnormal ciliary motility (HP:0012262) | 3.31909776 |
| 22 | Hemiparesis (HP:0001269) | 3.18968588 |
| 23 | Renal dysplasia (HP:0000110) | 3.18252262 |
| 24 | Hypothermia (HP:0002045) | 3.16228554 |
| 25 | Focal seizures (HP:0007359) | 3.15408998 |
| 26 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.04819740 |
| 27 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.04819740 |
| 28 | Absent hair (HP:0002298) | 3.03397433 |
| 29 | Visual hallucinations (HP:0002367) | 2.93409109 |
| 30 | Erythroderma (HP:0001019) | 2.86264857 |
| 31 | Hypoglycemic coma (HP:0001325) | 2.74007117 |
| 32 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.73331165 |
| 33 | Hypoglycemic seizures (HP:0002173) | 2.72970631 |
| 34 | Gait imbalance (HP:0002141) | 2.72761284 |
| 35 | Torticollis (HP:0000473) | 2.70714360 |
| 36 | Broad-based gait (HP:0002136) | 2.70417711 |
| 37 | Ectropion (HP:0000656) | 2.69192188 |
| 38 | Febrile seizures (HP:0002373) | 2.67228795 |
| 39 | Polyphagia (HP:0002591) | 2.65680042 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.64949088 |
| 41 | Amblyopia (HP:0000646) | 2.64794161 |
| 42 | Epileptic encephalopathy (HP:0200134) | 2.64108719 |
| 43 | Intention tremor (HP:0002080) | 2.62623356 |
| 44 | Ankle clonus (HP:0011448) | 2.61259289 |
| 45 | Ketoacidosis (HP:0001993) | 2.60183539 |
| 46 | Chronic sinusitis (HP:0011109) | 2.55852978 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 2.53127519 |
| 48 | Vertebral arch anomaly (HP:0008438) | 2.51146578 |
| 49 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.49735063 |
| 50 | Rhinitis (HP:0012384) | 2.47719762 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.46312414 |
| 52 | Status epilepticus (HP:0002133) | 2.45190320 |
| 53 | Intestinal atresia (HP:0011100) | 2.44151560 |
| 54 | Pheochromocytoma (HP:0002666) | 2.43201332 |
| 55 | Hyperactive renin-angiotensin system (HP:0000841) | 2.41118814 |
| 56 | Double outlet right ventricle (HP:0001719) | 2.40536563 |
| 57 | Congenital malformation of the right heart (HP:0011723) | 2.40536563 |
| 58 | Focal dystonia (HP:0004373) | 2.37232930 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.36931220 |
| 60 | Drooling (HP:0002307) | 2.35047758 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.34985567 |
| 62 | Mitral stenosis (HP:0001718) | 2.34928460 |
| 63 | Osteomalacia (HP:0002749) | 2.34478081 |
| 64 | Chronic hepatic failure (HP:0100626) | 2.33115743 |
| 65 | Metabolic alkalosis (HP:0200114) | 2.32809495 |
| 66 | Postural tremor (HP:0002174) | 2.29828979 |
| 67 | Papilledema (HP:0001085) | 2.27798463 |
| 68 | Hyperglycemia (HP:0003074) | 2.26407824 |
| 69 | Symptomatic seizures (HP:0011145) | 2.24965324 |
| 70 | Atonic seizures (HP:0010819) | 2.24096787 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.23493975 |
| 72 | Muscular hypotonia of the trunk (HP:0008936) | 2.23112896 |
| 73 | Absence seizures (HP:0002121) | 2.21911023 |
| 74 | Decreased circulating renin level (HP:0003351) | 2.21779791 |
| 75 | Postural instability (HP:0002172) | 2.21632920 |
| 76 | Generalized tonic-clonic seizures (HP:0002069) | 2.21179683 |
| 77 | Palmoplantar hyperkeratosis (HP:0000972) | 2.20897519 |
| 78 | Truncal ataxia (HP:0002078) | 2.20830047 |
| 79 | Hypocalcemia (HP:0002901) | 2.19193794 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.18807343 |
| 81 | Genetic anticipation (HP:0003743) | 2.17865834 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.16517183 |
| 83 | Akinesia (HP:0002304) | 2.16501054 |
| 84 | Hyperventilation (HP:0002883) | 2.15819238 |
| 85 | Excessive salivation (HP:0003781) | 2.14182638 |
| 86 | Neoplasm of the lung (HP:0100526) | 2.13171793 |
| 87 | Spastic gait (HP:0002064) | 2.11698837 |
| 88 | Keratitis (HP:0000491) | 2.11261307 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10989692 |
| 90 | Enlarged penis (HP:0000040) | 2.09727385 |
| 91 | Dysdiadochokinesis (HP:0002075) | 2.08894212 |
| 92 | Palmar hyperkeratosis (HP:0010765) | 2.07475074 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.07175508 |
| 94 | Generalized myoclonic seizures (HP:0002123) | 2.07131651 |
| 95 | Action tremor (HP:0002345) | 2.06406711 |
| 96 | Poor suck (HP:0002033) | 2.05068992 |
| 97 | Nephrogenic diabetes insipidus (HP:0009806) | 2.04439212 |
| 98 | Plagiocephaly (HP:0001357) | 2.04373304 |
| 99 | Dialeptic seizures (HP:0011146) | 2.03747587 |
| 100 | Impaired smooth pursuit (HP:0007772) | 2.02990484 |
| 101 | Prolonged QT interval (HP:0001657) | 2.01751270 |
| 102 | Bradykinesia (HP:0002067) | 2.01528563 |
| 103 | Craniofacial dystonia (HP:0012179) | 2.00418439 |
| 104 | Blepharitis (HP:0000498) | 2.00279522 |
| 105 | Hyperthyroidism (HP:0000836) | 1.99661418 |
| 106 | Hyperaldosteronism (HP:0000859) | 1.97467200 |
| 107 | Sleep apnea (HP:0010535) | 1.96337685 |
| 108 | Poor eye contact (HP:0000817) | 1.92017958 |
| 109 | Aqueductal stenosis (HP:0002410) | 1.91755583 |
| 110 | Small epiphyses (HP:0010585) | 1.90833304 |
| 111 | Impaired vibratory sensation (HP:0002495) | 1.90275621 |
| 112 | Mutism (HP:0002300) | 1.89120807 |
| 113 | Dysmetria (HP:0001310) | 1.88499816 |
| 114 | Genital tract atresia (HP:0001827) | 1.87925799 |
| 115 | Widely spaced teeth (HP:0000687) | 1.87696064 |
| 116 | Abnormality of binocular vision (HP:0011514) | 1.87140432 |
| 117 | Diplopia (HP:0000651) | 1.87140432 |
| 118 | Retinal atrophy (HP:0001105) | 1.86426127 |
| 119 | Diminished movement (HP:0002374) | 1.85754411 |
| 120 | Specific learning disability (HP:0001328) | 1.84587971 |
| 121 | Failure to thrive in infancy (HP:0001531) | 1.83896768 |
| 122 | Vaginal atresia (HP:0000148) | 1.82950288 |
| 123 | Erythema (HP:0010783) | 1.81645030 |
| 124 | Vertigo (HP:0002321) | 1.81556511 |
| 125 | Absent speech (HP:0001344) | 1.81536475 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81020718 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80287769 |
| 128 | Choreoathetosis (HP:0001266) | 1.79624550 |
| 129 | Amelogenesis imperfecta (HP:0000705) | 1.78290297 |
| 130 | Methylmalonic acidemia (HP:0002912) | 1.77742561 |
| 131 | Abnormality of vitamin B metabolism (HP:0004340) | 1.75239006 |
| 132 | Renal agenesis (HP:0000104) | 1.74946066 |
| 133 | Type II lissencephaly (HP:0007260) | 1.74636359 |
| 134 | Abnormality of the corticospinal tract (HP:0002492) | 1.74579483 |
| 135 | Hepatoblastoma (HP:0002884) | 1.74564973 |
| 136 | Abnormal EKG (HP:0003115) | 1.73911956 |
| 137 | Spastic tetraplegia (HP:0002510) | 1.73062664 |
| 138 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.72720397 |
| 139 | Large for gestational age (HP:0001520) | 1.72057941 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 1.71855644 |
| 141 | Neoplasm of the respiratory system (HP:0100606) | 1.71478825 |
| 142 | Corneal erosion (HP:0200020) | 1.71340226 |
| 143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.71081642 |
| 144 | Syncope (HP:0001279) | 1.70542030 |
| 145 | EEG with generalized epileptiform discharges (HP:0011198) | 1.69444460 |
| 146 | Impaired social interactions (HP:0000735) | 1.65700856 |
| 147 | Abnormal social behavior (HP:0012433) | 1.65700856 |
| 148 | Hypokalemia (HP:0002900) | 1.65665794 |
| 149 | Abnormality of potassium homeostasis (HP:0011042) | 1.63501867 |
| 150 | Abnormal drinking behavior (HP:0030082) | 1.62785250 |
| 151 | Polydipsia (HP:0001959) | 1.62785250 |
| 152 | Anxiety (HP:0000739) | 1.62052608 |
| 153 | Increased circulating renin level (HP:0000848) | 1.60487794 |
| 154 | Spinal canal stenosis (HP:0003416) | 1.60392354 |
| 155 | Agitation (HP:0000713) | 1.59310888 |
| 156 | Arthropathy (HP:0003040) | 1.58973332 |
| 157 | Hypsarrhythmia (HP:0002521) | 1.58808605 |
| 158 | Gaze-evoked nystagmus (HP:0000640) | 1.58324268 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.58057428 |
| 160 | Hypohidrosis (HP:0000966) | 1.58036308 |
| 161 | Cutaneous finger syndactyly (HP:0010554) | 1.55147601 |
| 162 | Ulnar claw (HP:0001178) | 1.54041082 |
| 163 | Abnormal biliary tract physiology (HP:0012439) | 1.53921785 |
| 164 | Bile duct proliferation (HP:0001408) | 1.53921785 |
| 165 | Depression (HP:0000716) | 1.53193375 |
| 166 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.52946605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 7.61816803 |
| 2 | SIK2 | 5.72192676 |
| 3 | SIK1 | 4.54958374 |
| 4 | NTRK3 | 3.66196771 |
| 5 | EPHA4 | 3.45045108 |
| 6 | MARK3 | 2.36208597 |
| 7 | FGFR2 | 2.31345273 |
| 8 | MAP3K12 | 2.15259417 |
| 9 | PRKD3 | 2.03270059 |
| 10 | INSRR | 1.90255584 |
| 11 | EPHA2 | 1.81347049 |
| 12 | MAP3K9 | 1.77091947 |
| 13 | MAP3K4 | 1.72309398 |
| 14 | MARK2 | 1.72023518 |
| 15 | PRPF4B | 1.69870468 |
| 16 | TNIK | 1.66019717 |
| 17 | MAP2K7 | 1.65588463 |
| 18 | STK38 | 1.52969430 |
| 19 | DAPK2 | 1.50768701 |
| 20 | MARK1 | 1.50521971 |
| 21 | MAP2K4 | 1.45664221 |
| 22 | LATS1 | 1.45655658 |
| 23 | RIPK4 | 1.35450574 |
| 24 | MAPK13 | 1.33754719 |
| 25 | NTRK1 | 1.31996922 |
| 26 | LATS2 | 1.26155602 |
| 27 | PAK4 | 1.23381801 |
| 28 | CAMK1 | 1.22405588 |
| 29 | MAP3K2 | 1.22317622 |
| 30 | MAP4K2 | 1.21642301 |
| 31 | MINK1 | 1.19713452 |
| 32 | NTRK2 | 1.16959453 |
| 33 | WNK1 | 1.10606907 |
| 34 | CSNK1G1 | 1.09511489 |
| 35 | SGK2 | 1.06307718 |
| 36 | PAK6 | 1.05395630 |
| 37 | OXSR1 | 1.04754040 |
| 38 | AKT3 | 1.01529429 |
| 39 | MAP2K6 | 0.98179369 |
| 40 | CASK | 0.94396847 |
| 41 | CAMKK1 | 0.93359781 |
| 42 | CDK5 | 0.92390175 |
| 43 | SGK494 | 0.90396719 |
| 44 | SGK223 | 0.90396719 |
| 45 | ADRBK2 | 0.89407985 |
| 46 | GRK5 | 0.88843703 |
| 47 | CDK8 | 0.88696469 |
| 48 | MAP3K1 | 0.85492475 |
| 49 | GRK1 | 0.85107071 |
| 50 | MAP3K13 | 0.79649855 |
| 51 | SGK3 | 0.79328439 |
| 52 | PRKCH | 0.75810942 |
| 53 | UHMK1 | 0.74895376 |
| 54 | TAOK3 | 0.74083300 |
| 55 | TAOK1 | 0.72549013 |
| 56 | STK38L | 0.71424943 |
| 57 | PRKCG | 0.70624054 |
| 58 | ALK | 0.69187863 |
| 59 | BMPR2 | 0.68491071 |
| 60 | FES | 0.68037030 |
| 61 | TRPM7 | 0.67269041 |
| 62 | CAMK4 | 0.67174915 |
| 63 | DAPK1 | 0.67120295 |
| 64 | CAMK2A | 0.65677874 |
| 65 | PRKCZ | 0.65637092 |
| 66 | ERBB3 | 0.63844192 |
| 67 | HIPK2 | 0.63762014 |
| 68 | SGK1 | 0.63123700 |
| 69 | KSR2 | 0.62000792 |
| 70 | CSNK1G2 | 0.61255846 |
| 71 | EPHA3 | 0.61152321 |
| 72 | CDK19 | 0.57742230 |
| 73 | STK39 | 0.55222335 |
| 74 | CAMKK2 | 0.55176090 |
| 75 | TNK2 | 0.53597031 |
| 76 | WNK4 | 0.53532573 |
| 77 | FGFR3 | 0.53238503 |
| 78 | CSNK1D | 0.52321879 |
| 79 | DYRK2 | 0.52118856 |
| 80 | CAMK2G | 0.50147120 |
| 81 | TRIM28 | 0.49965430 |
| 82 | LIMK1 | 0.49589740 |
| 83 | TESK1 | 0.48746276 |
| 84 | STK11 | 0.48023381 |
| 85 | PTK2B | 0.47305219 |
| 86 | PLK2 | 0.45953572 |
| 87 | BMPR1B | 0.45870105 |
| 88 | ACVR1B | 0.45704257 |
| 89 | CAMK1D | 0.45084758 |
| 90 | PRKCE | 0.43985078 |
| 91 | CSNK1A1L | 0.43159102 |
| 92 | PRKAA1 | 0.42920793 |
| 93 | CDK3 | 0.42468410 |
| 94 | CDC42BPA | 0.42273435 |
| 95 | RET | 0.41997623 |
| 96 | CDK18 | 0.41644629 |
| 97 | CDK15 | 0.41326186 |
| 98 | CDK14 | 0.41274200 |
| 99 | CSNK1E | 0.41183113 |
| 100 | PRKG1 | 0.40985677 |
| 101 | WNK3 | 0.40960502 |
| 102 | IRAK2 | 0.40399262 |
| 103 | ARAF | 0.39940578 |
| 104 | KSR1 | 0.39694987 |
| 105 | DYRK1A | 0.36857400 |
| 106 | PNCK | 0.36442914 |
| 107 | PAK3 | 0.35737347 |
| 108 | CSNK1G3 | 0.34853350 |
| 109 | PRKACB | 0.34086561 |
| 110 | CAMK2B | 0.33543709 |
| 111 | CDK11A | 0.32792206 |
| 112 | FER | 0.32040115 |
| 113 | RPS6KA3 | 0.30862995 |
| 114 | FYN | 0.28728086 |
| 115 | PKN1 | 0.27887277 |
| 116 | PASK | 0.27344637 |
| 117 | CAMK1G | 0.26967223 |
| 118 | MAP3K7 | 0.26764902 |
| 119 | CSNK1A1 | 0.26589649 |
| 120 | FGR | 0.26485497 |
| 121 | PRKD2 | 0.26073282 |
| 122 | MAPK10 | 0.25022361 |
| 123 | MAPK15 | 0.24973302 |
| 124 | FRK | 0.24313070 |
| 125 | NEK6 | 0.23597135 |
| 126 | PRKCA | 0.23220931 |
| 127 | PDK1 | 0.22647389 |
| 128 | CAMK2D | 0.21893856 |
| 129 | PRKACA | 0.21870039 |
| 130 | PHKG1 | 0.20626763 |
| 131 | PHKG2 | 0.20626763 |
| 132 | PINK1 | 0.20614037 |
| 133 | ADRBK1 | 0.20485315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.50026152 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88960831 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.65658395 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53478223 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.52284402 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51837429 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.47240268 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35323043 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.18777419 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.17926335 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12516536 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.11346990 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.06995508 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.02112476 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.99333927 |
| 16 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.92225482 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89278145 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82866989 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.80725704 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.79458688 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78902928 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68716896 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.67050557 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61505162 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59049659 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.58159135 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.56666982 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.53400477 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.49072519 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.43376444 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.41998358 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38811637 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31122829 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30104407 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23804177 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20549159 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18027594 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14236125 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13409171 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12470642 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11321897 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10693712 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09718992 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07864701 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07712614 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 0.97954251 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97681497 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97380809 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.96168819 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95546815 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94482500 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90265923 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89691243 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88016209 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84638555 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84246135 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.84026996 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82886355 |
| 59 | Protein export_Homo sapiens_hsa03060 | 0.82810861 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80784111 |
| 61 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80190599 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75819974 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75431549 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75008725 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73604359 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73456132 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.72948027 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71641073 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71240697 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70520699 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68469559 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67783122 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66968611 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66398865 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66320077 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64517192 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63867485 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.63602568 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63359310 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63189060 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63171021 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62864713 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61212291 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60811553 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60573333 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58602378 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.57998140 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55407645 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55209782 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.54625995 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54590538 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53539870 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52446534 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51528273 |
| 95 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50308899 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44579445 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42789583 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42171065 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42015787 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41062835 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40492402 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.39741470 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37165113 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37161817 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35607257 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33571777 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.33476655 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33021255 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.32794950 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31667516 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31522645 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30909524 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30707880 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29354421 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27423845 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27408109 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27317797 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.26955220 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.26896254 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26696005 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26611581 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24162218 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24097504 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.23533427 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22901784 |

